| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Flutiform 50/5, Druckgasinhalation, Suspension | | 63032 | | 01 | | Flutiform 50/5 | | Druckgasinhalation, Suspension | | R03AK11 | | Formoterol and Fluticasone | | 20.01.2014 | | |
| | Zusammensetzung | | fluticasoni propionas 50 µg pro dosi, formoteroli fumaras dihydricus 5 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. | | Packungsbestandteile | | Druckgasinhalation | | | | | | | | Wirkstoffe | Stärke |
|---|
| Fluticasoni Propionas | 50 µg | | Formoteroli Fumaras Dihydricus | 5 µg |
| | BAG: Wirkstoffe | Stärke |
|---|
| Fluticasoni-17 Propionas | 50 mcg | | Formoteroli Fumaras Dihydricus | 5 mcg |
| | | | Hilfsstoffe | Stärke |
|---|
| Apafluranum ad Aerosolum | | | Ethanol | 1 mg | | Natrium Cromoglicat | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | 120 | 30.89 | 50.00 | B | SL | Nein |
|
|
